内視鏡的粘膜下層剥離術（ESD）市場 – 2030年までの世界予測

本レポートは、内視鏡的粘膜下層剥離術（ESD）市場を評価し、製品、適応症、エンドユーザー、地域など、様々なセグメントにおける市場規模と将来の成長可能性を予測しています。さらに、主要企業の競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても解説しています。
本レポートは、内視鏡的粘膜下層剥離術（ESD）市場全体とそのサブセグメントの収益予測に関する貴重なデータを提供し、市場リーダーと新規参入企業の双方にメリットをもたらします。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、効果的な市場開拓戦略を策定するのに役立ちます。さらに、本レポートは、主要な推進要因、課題、制約、機会など、市場動向に関する洞察をステークホルダーに提供します。

内視鏡的粘膜下層剥離術（ESD）市場は、予測期間中に8.4%のCAGRで成長し、2025年の5億米ドルから2030年には7億5,000万米ドルに達すると予測されています。

内視鏡的粘膜下層剥離術（ESD）ツールの技術的進歩は、この手技の臨床的有用性と安全性を著しく向上させ、市場の成長を牽引しています。注入機能と切開機能を兼ね備えたハイブリッドナイフなどの革新的技術は、剥離プロセスを合理化し、手技時間を短縮しました。さらに、牽引補助システムにより粘膜下層への可視化とアクセスが向上し、複雑な剥離がより容易になりました。

The endoscopic submucosal dissection market is projected to reach USD 0.75 billion by 2030 from USD 0.50 billion in 2025, at a CAGR of 8.4% during the forecast period.

Technological advancements in endoscopic submucosal dissection (ESD) tools are significantly enhancing the procedure’s clinical utility and safety, which, in turn, is driving market growth. Innovations such as hybrid knives that combine both injection and cutting capabilities have streamlined the dissection process and reduced procedural time. Additionally, traction-assisted systems have improved visualization and access to submucosal layers, making complex dissections more manageable.

High-definition and narrow-band imaging (NBI) endoscopes have further enhanced the detection of lesions and assessment of margins, resulting in increased procedural accuracy and better patient outcomes. Companies like Olympus and Fujifilm are heavily investing in platform-specific innovations, integrating energy delivery systems, ergonomic endoscope designs, and AI-based visualization aids.

These developments are reducing the technical barriers traditionally associated with ESD, enabling broader adoption in non-academic and community healthcare settings. As these tools become more intuitive and standardized, they are facilitating the learning process for new practitioners, ultimately making ESD more accessible and preferred for the management of early-stage gastrointestinal tumors worldwide.

By product, the gastroscopes & endoscopes segment accounted for the largest share of the market in 2024.

The market for endoscopic submucosal dissection (ESD) is categorized by product type into gastroscopes & endoscopes, knives, injection agents, tissue retractors, grasping clips, and other products. In 2024, the segment for gastroscopes & endoscopes held the largest share of the global ESD market.

Recent advancements in high-definition (HD) and 4K ultra-high-definition (UHD) imaging technologies have transformed ESD procedures by providing superior optical clarity and detailed visualization. Features such as narrow-band imaging (NBI), magnification endoscopy, and 4K scopes significantly enhance the detection of lesions, delineation of margins, and overall procedural accuracy. These imaging enhancements reduce the likelihood of diagnostic errors and allow for more precise dissection, ultimately leading to improved patient outcomes. Consequently, gastroscopes & endoscopes play a vital role in these advancements, which is why they dominate the market share in the ESD sector, driven by their essential contribution to the success of these procedures.

Based on indications, the stomach cancer segment dominated the ESD market in 2024.

Based on indications, the ESD market is divided into three categories: stomach cancer, colon cancer, and esophageal cancer. In 2024, stomach cancer accounted for the largest share of the ESD market. Strong clinical evidence supports ESD as the gold standard for treating mucosal and superficial submucosal gastric tumors. Long-term studies have shown that ESD achieves high rates of en bloc resection, minimal local recurrence, and excellent organ preservation, especially when compared to traditional surgery. These outcomes are particularly significant for early-stage stomach cancers, where a curative approach without major surgery is preferred. Consequently, the stomach cancer segment leads the ESD market, driven by strong clinical validation and high procedural volumes in the management of gastric lesions.

Based on region, the Asia Pacific held the largest market share in 2024.

The Asia Pacific region is projected to hold the largest share of the ESD market during the forecast period. Government-funded screening programs in Japan and South Korea are actively promoting the early detection of gastric and colorectal lesions through endoscopy, which has significantly increased ESD volumes. This region has also been at the forefront of adopting advanced medical technology to enhance patient care and safety.

A breakdown of the primary participants (supply side) for the endoscopic submucosal dissection market referred to in this report is provided below:

• By Company Type: Tier 1 (34%), Tier 2 (38%), and Tier 3 (28%)
• By Designation: C-level Executives (26%), Directors (35%), and Others (39%)
• By Region: North America (17%), Europe (39%), Asia Pacific (28%), Latin America (8%), Middle East & Africa (3%), and GCC Countries (5%)

Prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic (Ireland), Boston Scientific Corporation (US), and Sumitomo Bakelite Co., Ltd. (Japan).

Research Coverage

The report assesses the endoscopic submucosal dissection market, estimating its size and future growth potential across various segments, including products, indications, end users, and regions. Additionally, the report features a competitive analysis of key players in the market, along with company profiles, product offerings, recent developments, and essential market strategies.

Reasons to Buy the Report

The report will provide valuable data on revenue estimates for the overall endoscopic submucosal dissection market and its subsegments, benefiting both market leaders and new entrants. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report will give stakeholders insights into market trends, including key drivers, challenges, restraints, and opportunities.

This report provides insights into the following points:

Analysis of key drivers (increasing use of endoscopy in detection and treatment procedures and rising prevalence of cancer), restraints (dearth of skilled professionals and high overhead cost of ESD procedures with limited reimbursements), opportunities (growing demand for minimally invasive procedures, growing investments in R&D of endoscopy technology, and expected increase in adoption of and preference for ESD procedures in developing countries), and challenges (higher rate of complications and risk of post-operative infections).

• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ESD market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, indication, end user, and region.
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ESD market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ESD market.

Table of Contents

1               INTRODUCTION              23

1.1           STUDY OBJECTIVES       23

1.2           MARKET DEFINITION   23

1.3           STUDY SCOPE   24

1.3.1        SEGMENTS COVERED    24

1.3.2        INCLUSIONS AND EXCLUSIONS 25

1.4           YEARS CONSIDERED      25

1.5           CURRENCY USED             26

1.6           STAKEHOLDERS               26

1.7           LIMITATIONS    27

1.8           SUMMARY OF CHANGES               27

2               RESEARCH METHODOLOGY       28

2.1           RESEARCH DATA              28

2.1.1        SECONDARY DATA          28

2.1.1.1    Key data from secondary sources       30

2.1.2        PRIMARY DATA 30

2.1.2.1    Key data from primary sources           31

2.1.2.2    Key industry insights           32

2.2           MARKET SIZE ESTIMATION         34

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 39

2.4           MARKET SHARE ESTIMATION    41

2.5           STUDY ASSUMPTIONS  41

2.6           METHODOLOGY-RELATED LIMITATIONS           41

2.7           RISK ASSESSMENT           42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       46

4.1           ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW          46

4.2           ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT AND COUNTRY    47

4.3           ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX           48

4.4           ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION                48

4.5           ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS              49

5               MARKET OVERVIEW       50

5.1           INTRODUCTION              50

5.2           MARKET DYNAMICS       50

5.2.1        DRIVERS               51

5.2.1.1    Increasing use of endoscopy in detection and treatment procedures             51

5.2.1.2    Rising prevalence of cancer 51

5.2.1.3    Growing geriatric population              52

5.2.2        RESTRAINTS      53

5.2.2.1    Dearth of skilled professionals            53

5.2.2.2    High overhead cost of ESD procedures with limited reimbursements    53

5.2.3        OPPORTUNITIES              53

5.2.3.1    Growing demand for minimally invasive procedures      53

5.2.3.2    Expected increase in adoption of and preference for ESD procedures in developing countries   54

5.2.4        CHALLENGES    54

5.2.4.1    Higher rate of complications               54

5.2.4.2    Risk of post-operative infection          54

5.3           INDUSTRY TRENDS         55

5.3.1        ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION        55

5.3.2        ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION      56

5.4           REGULATORY ANALYSIS               57

5.4.1        REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  57

5.4.2        REGULATORY LANDSCAPE         59

5.4.2.1    North America      59

5.4.2.1.1 US           59

5.4.2.1.2 Canada   59

5.4.2.2    Europe   60

5.4.2.2.1 Germany                 60

5.4.2.2.2 France    61

5.4.2.2.3 UK          61

5.4.2.2.4 Italy         61

5.5           MARKET ECOSYSTEM    61

5.6           VALUE CHAIN ANALYSIS               63

5.7           PORTER’S FIVE FORCES ANALYSIS           64

5.7.1        THREAT OF NEW ENTRANTS      65

5.7.1.1    High capital requirement    65

5.7.1.2    High preference for products from well-established brands                 66

5.7.2        THREAT OF SUBSTITUTES          66

5.7.2.1    Presence of substitute therapies for endoscopic submucosal dissection               66

5.7.3        BARGAINING POWER OF SUPPLIERS       66

5.7.3.1    Presence of several raw material suppliers       66

5.7.3.2    Supplier switching cost        66

5.7.4        BARGAINING POWER OF BUYERS             66

5.7.4.1    Limited number of companies offering premium products at global level             66

5.7.5        INTENSITY OF COMPETITIVE RIVALRY 66

5.7.5.1    Increasing demand for high-quality and innovative products                 67

5.7.5.2    Lucrative growth potential in emerging markets             67

5.8           PRICING ANALYSIS          67

5.8.1        AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024 67

5.8.2        AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD)             68

5.9           PATENT ANALYSIS          69

5.10         SUPPLY CHAIN ANALYSIS             72

5.11         KEY CONFERENCES AND EVENTS DURING 2025–2025                 74

5.12         KEY STAKEHOLDERS AND BUYING CRITERIA     75

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           75

5.12.2      BUYING CRITERIA           75

5.13         TRENDS/DISRUPTIONS AFFECTING CUSTOMER BUSINESS            76

5.13.1      TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS            76

5.14         TRADE ANALYSIS             77

5.14.1      IMPORT DATA  77

5.14.2      EXPORT DATA  78

5.15         TECHNOLOGY ANALYSIS             80

5.15.1      KEY TECHNOLOGIES     80

5.15.1.1  Endoscopic electrosurgical knives      80

5.15.1.2  High-definition endoscopes                81

5.15.2      COMPLEMENTARY TECHNOLOGIES       81

5.15.2.1  Narrow band imaging/i-scan/FICE  81

5.15.2.2  Optical coherence tomography (OCT)             82

5.15.3      ADJACENT TECHNOLOGIES       82

5.15.3.1  Endoscopic mucosal resection            82

5.15.3.2  Full-thickness resection devices         83

5.16         ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ADJACENT MARKET        83

5.17         CASE STUDY ANALYSIS 83

5.17.1      ROBOTIC-ASSISTED ESD FOR ESOPHAGEAL TUMORS                 83

5.17.2      COST-EFFECTIVE ESD DEVICES FOR STOMACH CANCER                 84

5.17.3      PRECISION ESD FOR COLORECTAL CANCER LESIONS                 84

5.18         IMPACT OF AI/GEN AI ON ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET    85

5.18.1      MARKET POTENTIAL OF AI IN ENDOSCOPIC SUBMUCOSAL

DISSECTION MARKET    85

5.18.2      AI USE CASES     86

5.18.3      KEY COMPANIES IMPLEMENTING AI      86

5.18.4      FUTURE OF GENERATIVE AI IN ENDOSCOPIC SUBMUCOSAL

DISSECTION MARKET    87

5.19         IMPACT OF 2025 US TARIFF ON ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET      87

5.19.1      KEY TARIFF RATES          88

5.19.2      PRICE IMPACT ANALYSIS             88

5.19.3      IMPACT ON END-USE INDUSTRIES          89

5.20         INVESTMENT & FUNDING SCENARIO     89

6               ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT           92

6.1           INTRODUCTION              93

6.2           GASTROSCOPES & COLONOSCOPES       93

6.2.1        RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH             93

6.3           KNIVES 95

6.3.1        IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS

OF KNIVES TO DRIVE MARKET GROWTH              95

6.4           INJECTION AGENTS        96

6.4.1        NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH             96

6.5           TISSUE RETRACTORS     98

6.5.1        RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION         98

6.6           GRASPERS/CLIPS              100

6.6.1        PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS

TO DRIVE DEMAND        100

6.7           OTHER PRODUCTS         101

7               ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION      103

7.1           INTRODUCTION              104

7.2           STOMACH CANCER         105

7.2.1        SIGNIFICANT PROPORTION OF CANCER DEATHS TO DRIVE SEGMENT              105

7.3           COLON CANCER               107

7.3.1        INTEREST BY MEDICAL DEVICE MANUFACTURERS, CLINICAL INVESTIGATORS, AND PRACTICING CLINICIANS TO DRIVE MARKET 107

7.4           ESOPHAGEAL CANCER  109

7.4.1        GROWING PREVALENCE OF ESOPHAGEAL CANCER TO FUEL GROWTH 109

8               ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER            111

8.1           INTRODUCTION              112

8.2           HOSPITALS         112

8.2.1        GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES

AND ESD PROCEDURES TO SUPPORT GROWTH                112

8.3           SPECIALTY CLINICS        114

8.3.1        TRANSITION FROM HOSPITAL-BASED PROCEDURES TO

CLINIC-BASED PROCEDURES TO BOOST GROWTH          114

8.4           AMBULATORY SURGICAL CENTERS        115

8.4.1        GROWTH IN SEGMENT DRIVEN BY INCREASING NUMBER

OF OUTPATIENT VISITS               115

8.5           OTHER END USERS         117

9               ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION                118

9.1           INTRODUCTION              119

9.2           ASIA PACIFIC     119

9.2.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 119

9.2.2        JAPAN   122

9.2.2.1    Supportive medical device reimbursement policies to drive market growth       122

9.2.3        CHINA  124

9.2.3.1    Large patient population and strong need for healthcare infrastructure improvements to boost market growth    124

9.2.4        INDIA    126

9.2.4.1    Favorable government initiatives for healthcare infrastructure improvements to support market growth          126

9.2.5        SOUTH KOREA  128

9.2.5.1    Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth             128

9.2.6        AUSTRALIA         130

9.2.6.1    High incidence of cancer to propel market growth         130

9.2.7        REST OF ASIA PACIFIC   132

9.3           NORTH AMERICA             133

9.3.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 133

9.3.2        US           136

9.3.2.1    Largest market for endoscopic submucosal dissection products                 136

9.3.3        CANADA               138

9.3.3.1    Slower healthcare development over past decade to restrain growth    138

9.4           EUROPE               141

9.4.1        MACROECONOMIC OUTLOOK FOR EUROPE      141

9.4.2        GERMANY           143

9.4.2.1    Germany to account for largest share of European market                 143

9.4.3        FRANCE                145

9.4.3.1    High-quality healthcare system offering coverage to all citizens to support market growth        145

9.4.4        UK          147

9.4.4.1    Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market  147

9.4.5        ITALY    149

9.4.5.1    Receptivity of government toward high-quality and technologically advanced equipment to foster growth    149

9.4.6        SPAIN    151

9.4.6.1    Rising prevalence of cancer to drive market growth       151

9.4.7        REST OF EUROPE             153

9.5           LATIN AMERICA                154

9.5.1        INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY TO FAVOR MARKET GROWTH 154

9.5.2        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 155

9.5.3        BRAZIL 157

9.5.3.1    Increase in private healthcare investments and rise in medical tourism to aid market growth              157

9.5.4        MEXICO                158

9.5.4.1    Increased government investment in healthcare infrastructure and technological advancements to aid market growth  158

9.5.5        REST OF LATIN AMERICA             160

9.6           MIDDLE EAST & AFRICA                162

9.6.1        ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE TO CREATE

NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES                 162

9.6.2        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 162

9.7           GCC COUNTRIES              164

9.7.1        INCREASING INVESTMENT IN HEALTHCARE INFRASTRUCTURE AND GROWING MEDICAL TOURISM TO PROPEL MARKET GROWTH         164

9.7.2        MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 164

10            COMPETITIVE LANDSCAPE         166

10.1         OVERVIEW          166

10.2         KEY PLAYER STRATEGY/RIGHT TO WIN                166

10.3         REVENUE ANALYSIS       168

10.4         MARKET SHARE ANALYSIS           170

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 172

10.5.1      STARS   172

10.5.2      EMERGING LEADERS     172

10.5.3      PERVASIVE PLAYERS      172

10.5.4      PARTICIPANTS 172

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         174

10.5.5.1  Company footprint               174

10.5.5.2  Region footprint   175

10.5.5.3  Product footprint  176

10.5.5.4  Indication footprint              177

10.5.5.5  End user footprint                 177

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        178

10.6.1      PROGRESSIVE COMPANIES         178

10.6.2      RESPONSIVE COMPANIES            178

10.6.3      DYNAMIC COMPANIES  178

10.6.4      STARTING BLOCKS         178

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 180

10.6.5.1  Detailed list of key startups/SMEs    180

10.6.5.2  Competitive benchmarking of key startups/SMEs          181

10.7         COMPANY VALUATION AND FINANCIAL METRICS                 182

10.7.1      FINANCIAL METRICS      182

10.7.2      COMPANY VALUATION 183

10.8         BRAND/PRODUCT COMPARISON             183

10.9         COMPETITIVE SCENARIO             184

10.9.1      PRODUCT LAUNCHES   184

10.9.2      DEALS  185

10.9.3      EXPANSIONS     186

11            COMPANY PROFILES      187

11.1         KEY PLAYERS     187

11.1.1      OLYMPUS CORPORATION           187

11.1.1.1  Business overview 187

11.1.1.2  Products offered   188

11.1.1.3  Recent developments           189

11.1.1.3.1                Deals      189

11.1.1.3.2                Expansions             190

11.1.1.4  MnM view              190

11.1.1.4.1                Right to win           190

11.1.1.4.2                Strategic choices   190

11.1.1.4.3                Weaknesses and competitive threats 190

11.1.2      MEDTRONIC      191

11.1.2.1  Business overview 191

11.1.2.2  Products offered   192

11.1.2.3  MnM view              193

11.1.2.3.1                Right to win           193

11.1.2.3.2                Strategic choices   193

11.1.2.3.3                Weaknesses and competitive threats 193

11.1.3      FUJIFILM HOLDINGS CORPORATION     194

11.1.3.1  Business overview 194

11.1.3.2  Products offered   195

11.1.3.3  Recent developments           195

11.1.3.3.1                Product launches & approvals            195

11.1.3.3.2                Deals      196

11.1.3.4  MnM view              196

11.1.3.4.1                Right to win           196

11.1.3.4.2                Strategic choices   196

11.1.3.4.3                Weaknesses and competitive threats 196

11.1.4      BOSTON SCIENTIFIC CORPORATION     197

11.1.4.1  Business overview 197

11.1.4.2  Products offered   198

11.1.4.3  MnM view              199

11.1.4.3.1                Right to win           199

11.1.4.3.2                Strategic choices   199

11.1.4.3.3                Weaknesses and competitive threats 199

11.1.5      SUMITOMO BAKELITE CO., LTD.              200

11.1.5.1  Business overview 200

11.1.5.2  Products offered   201

11.1.5.3  MnM view              201

11.1.5.3.1                Right to win           201

11.1.5.3.2                Strategic choices   201

11.1.5.3.3                Weaknesses and competitive threats 201

11.1.6      CREO MEDICAL GROUP PLC       202

11.1.6.1  Business overview 202

11.1.6.2  Products offered   203

11.1.6.3  Recent developments           203

11.1.6.3.1                Deals      203

11.1.6.3.2                Expansions             203

11.1.7      HOYA CORPORATION   204

11.1.7.1  Business overview 204

11.1.7.2  Products offered   205

11.1.8      CONMED CORPORATION             207

11.1.8.1  Business overview 207

11.1.8.2  Products offered   208

11.1.9      STERIS  209

11.1.9.1  Business overview 209

11.1.9.2  Products offered   210

11.1.9.3  Recent developments           211

11.1.9.3.1                Deals      211

11.1.10   MTW ENDOSKOPIE MANUFAKTUR          212

11.1.10.1                 Business overview 212

11.1.10.2                 Products offered   212

11.1.11   OVESCO ENDOSCOPY AG             213

11.1.11.1                 Business overview 213

11.1.11.2                 Products offered   213

11.1.12   ZEON MEDICAL INC.      214

11.1.12.1                 Business overview 214

11.1.12.2                 Products offered   214

11.1.13   MICRO-TECH ENDOSCOPY         215

11.1.13.1                 Business overview 215

11.1.13.2                 Products offered   215

11.1.13.3                 Recent developments           216

11.1.13.3.1             Product launches  216

11.1.14   KARL STORZ SE & CO. KG             217

11.1.14.1                 Business overview 217

11.1.14.2                 Products offered   217

11.1.15   COOK MEDICAL                218

11.1.15.1                 Business overview 218

11.1.15.2                 Products offered   218

11.1.15.3                 Recent developments           219

11.1.15.3.1             Product launches  219

11.2         OTHER COMPANIES       219

11.2.1      LEO MEDICAL CO., LTD.               219

11.2.2      ERBE ELEKTROMEDIZIN GMBH 220

11.2.3      TAEWOONG MEDICAL CO., LTD.              220

11.2.4      DCC HEALTHCARE          221

11.2.5      KOSSEN CO., LTD.            221

11.2.6      INNOVAMEDICA S.P.A.  222

11.2.7      JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.              223

11.2.8      HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.                 224

11.2.9      BEIJING ZKSK TECHNOLOGY CO., LTD. 224

11.2.10   UPEX-MED CO., LTD.     225

12            APPENDIX           226

12.1         DISCUSSION GUIDE        226

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                231

12.3         CUSTOMIZATION OPTIONS        233

12.4         RELATED REPORTS         233

12.5         AUTHOR DETAILS           234

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES                 26

TABLE 2                RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET    42

TABLE 3                GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+),

2020 VS. 2040       52

TABLE 4                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  57

TABLE 5                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  58

TABLE 6                REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT

AGENCIES, AND OTHER ORGANIZATIONS           58

TABLE 7                ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ROLE IN ECOSYSTEM 62

TABLE 8                ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:

PORTER’S FIVE FORCES ANALYSIS           64

TABLE 9                AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024 (USD)   67

TABLE 10              AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD)             68

TABLE 11              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY PATENTS, 2023–2025           70

TABLE 12              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:

CONFERENCES AND EVENTS, 2025–2026                 74

TABLE 13              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS           75

TABLE 14              KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 76

TABLE 15              IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020–2024 (USD THOUSAND)               78

TABLE 16              EXPORT DATA FOR HS CODE 901890, BY COUNTRY,

2020–2024 (USD THOUSAND)      79

TABLE 17              TYPES OF ELECTROSURGICAL KNIVES: FEATURES & USE CASES                80

TABLE 18              KEY COMPANIES IMPLEMENTING AI      86

TABLE 19              US-ADJUSTED RECIPROCAL TARIFF RATES                 88

TABLE 20              KEY PRODUCT-RELATED TARIFFS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION           88

TABLE 21              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            93

TABLE 22              GASTROSCOPES & COLONOSCOPES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     94

TABLE 23              KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 24              KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION,

2023–2030              96

TABLE 25              INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               97

TABLE 26              INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY REGION, 2023–2030    98

TABLE 27              TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               99

TABLE 28              TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY REGION, 2023–2030    99

TABLE 29              GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               100

TABLE 30              GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY REGION, 2023–2030    101

TABLE 31              OTHER PRODUCTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               102

TABLE 32              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)            104

TABLE 33              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2022 (NUMBER OF PROCEDURES)             104

TABLE 34              ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER,

BY REGION (2022–2040)  105

TABLE 35              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER,

BY COUNTRY, 2023–2030 (USD MILLION)               106

TABLE 36              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER,

BY REGION, 2024 (NUMBER OF PROCEDURES)   106

TABLE 37              ESTIMATED NUMBER OF NEW CASES OF COLON CANCER,

BY REGION (2022–2040)  107

TABLE 38              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER,

BY COUNTRY, 2023–2030 (USD MILLION)               108

TABLE 39              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER,

BY REGION, 2024 (NUMBER OF PROCEDURES)   108

TABLE 40              ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2022–2040) 109

TABLE 41              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER,

BY COUNTRY, 2023–2030 (USD MILLION)               110

TABLE 42              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER,

BY REGION, 2024 (NUMBER OF PROCEDURES)   110

TABLE 43              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            112

TABLE 44              HOSPITALS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               113

TABLE 45              SPECIALTY CLINICS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               115

TABLE 46              AMBULATORY SURGICAL CENTERS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     116

TABLE 47              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               117

TABLE 48              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION,

2023–2030 (USD MILLION)            119

TABLE 49              ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 121

TABLE 50              ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 121

TABLE 51              ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)            122

TABLE 52              ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               122

TABLE 53              JAPAN: MACROECONOMIC INDICATORS                 123

TABLE 54              JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            123

TABLE 55              JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)            124

TABLE 56              JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               124

TABLE 57              CHINA: MACROECONOMIC INDICATORS                 125

TABLE 58              CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               125

TABLE 59              CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          125

TABLE 60              CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               126

TABLE 61              INDIA: MACROECONOMIC INDICATORS                 127

TABLE 62              INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               127

TABLE 63              INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          127

TABLE 64              INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               128

TABLE 65              SOUTH KOREA: MACROECONOMIC INDICATORS      129

TABLE 66              SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               129

TABLE 67              SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          129

TABLE 68              SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               130

TABLE 69              AUSTRALIA: MACROECONOMIC INDICATORS                 130

TABLE 70              AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               131

TABLE 71              AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          131

TABLE 72              AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               131

TABLE 73              REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               132

TABLE 74              REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          133

TABLE 75              REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               133

TABLE 76              NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 77              NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               135

TABLE 78              NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          135

TABLE 79              NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               136

TABLE 80              US: MACROECONOMIC INDICATORS      137

TABLE 81              US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            137

TABLE 82              US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)            137

TABLE 83              US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            138

TABLE 84              AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040       139

TABLE 85              CANADA: MACROECONOMIC INDICATORS                 140

TABLE 86              CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            140

TABLE 87              CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)            140

TABLE 88              CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            141

TABLE 89              EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 90              EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            142

TABLE 91              EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)            143

TABLE 92              EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            143

TABLE 93              GERMANY: MACROECONOMIC INDICATORS                 144

TABLE 94              GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 144

TABLE 95              GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)            145

TABLE 96              GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)                 145

TABLE 97              FRANCE: MACROECONOMIC INDICATORS                 146

TABLE 98              FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            146

TABLE 99              FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)            147

TABLE 100            FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            147

TABLE 101            UK: MACROECONOMIC INDICATORS     148

TABLE 102            UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            148

TABLE 103            UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)            149

TABLE 104            UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            149

TABLE 105            ITALY: MACROECONOMIC INDICATORS                 150

TABLE 106            ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            150

TABLE 107            ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)            150

TABLE 108            ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            151

TABLE 109            SPAIN: MACROECONOMIC INDICATORS                 151

TABLE 110            SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            152

TABLE 111            SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)          152

TABLE 112            SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            152

TABLE 113            REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               153

TABLE 114            REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          154

TABLE 115            REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               154

TABLE 116            LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 117            LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               156

TABLE 118            LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          156

TABLE 119            LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               156

TABLE 120            BRAZIL: MACROECONOMIC INDICATORS                 157

TABLE 121            BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            157

TABLE 122            BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2023–2030 (USD MILLION)            158

TABLE 123            BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            158

TABLE 124            MEXICO: MACROECONOMIC INDICATORS                 159

TABLE 125            MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            159

TABLE 126            MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)            159

TABLE 127            MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2023–2030 (USD MILLION)            160

TABLE 128            REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               161

TABLE 129            REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          161

TABLE 130            REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               161

TABLE 131            MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               163

TABLE 132            MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          163

TABLE 133            MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               163

TABLE 134            GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               165

TABLE 135            GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY INDICATION, 2023–2030 (USD MILLION)          165

TABLE 136            GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,

BY END USER, 2023–2030 (USD MILLION)               165

TABLE 137            KEY DEVELOPMENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, JANUARY 2021–JUNE 2025                 167

TABLE 138            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : DEGREE OF COMPETITION   170

TABLE 139            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : REGION FOOTPRINT 175

TABLE 140            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT FOOTPRINT             176

TABLE 141            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: INDICATION FOOTPRINT        177

TABLE 142            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: END USER FOOTPRINT              177

TABLE 143            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY STARTUPS/SMES 180

TABLE 144            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION         181

TABLE 145            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT     181

TABLE 146            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES,

JANUARY 2021–JUNE 2025              184

TABLE 147            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS,

JANUARY 2021–JUNE 2025              185

TABLE 148            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: EXPANSIONS,

JANUARY 2021–JUNE 2025              186

TABLE 149            OLYMPUS CORPORATION: BUSINESS OVERVIEW          187

TABLE 150            OLYMPUS CORPORATION: PRODUCTS OFFERED             188

TABLE 151            OLYMPUS CORPORATION: DEALS, JANUARY 2021–JUNE 2025  189

TABLE 152            OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025              190

TABLE 153            MEDTRONIC: COMPANY OVERVIEW       191

TABLE 154            MEDTRONIC: PRODUCTS OFFERED        192

TABLE 155            FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW          194

TABLE 156            FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED    195

TABLE 157            FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JUNE 2025              195

TABLE 158            FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2025              196

TABLE 159            BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW          197

TABLE 160            BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED    198

TABLE 161            SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW          200

TABLE 162            SUMITOMO BAKELITE CO., LTD.: PRODUCTS OFFERED             201

TABLE 163            CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW          202

TABLE 164            CREO MEDICAL GROUP PLC: PRODUCTS OFFERED             203

TABLE 165            CREO MEDICAL GROUP PLC: DEALS, JANUARY 2021–JUNE 2025  203

TABLE 166            CREO MEDICAL GROUP PLC: EXPANSIONS, JANUARY 2021–JUNE 2025              203

TABLE 167            HOYA CORPORATION: BUSINESS OVERVIEW                 204

TABLE 168            HOYA CORPORATION: PRODUCTS OFFERED                 205

TABLE 169            CONMED CORPORATION: BUSINESS OVERVIEW                 207

TABLE 170            CONMED CORPORATION: PRODUCTS OFFERED             208

TABLE 171            STERIS: COMPANY OVERVIEW   209

TABLE 172            STERIS: PRODUCTS OFFERED    210

TABLE 173            STERIS: DEALS  211

TABLE 174            MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW          212

TABLE 175            MTW ENDOSKOPIE MANUFAKTUR: PRODUCTS OFFERED             212

TABLE 176            OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW                 213

TABLE 177            OVESCO ENDOSCOPY AG: PRODUCTS OFFERED                 213

TABLE 178            ZEON MEDICAL INC.: BUSINESS OVERVIEW                 214

TABLE 179            ZEON MEDICAL INC.: PRODUCTS OFFERED                 214

TABLE 180            MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW          215

TABLE 181            MICRO-TECH ENDOSCOPY: PRODUCTS OFFERED             215

TABLE 182            MICRO-TECH ENDOSCOPY: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025     216

TABLE 183            KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW                 217

TABLE 184            KARL STORZ SE & CO. KG.: PRODUCTS OFFERED                 217

TABLE 185            COOK MEDICAL: BUSINESS OVERVIEW 218

TABLE 186            COOK MEDICAL: PRODUCTS OFFERED 218

TABLE 187            COOK MEDICAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025              219

TABLE 188            LEO MEDICAL CO., LTD.: COMPANY OVERVIEW                 219

TABLE 189            ERBE ELEKTROMEDIZIN GMBH: COMPANY OVERVIEW          220

TABLE 190            TAEWOONG MEDICAL CO., LTD.: COMPANY OVERVIEW          220

TABLE 191            DCC HEALTHCARE: COMPANY OVERVIEW                 221

TABLE 192            KOSSEN CO., LTD.: COMPANY OVERVIEW                 221

TABLE 193            INNOVAMEDICA S.P.A.: COMPANY OVERVIEW                 222

TABLE 194            JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.:

COMPANY OVERVIEW   223

TABLE 195            HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: COMPANY OVERVIEW              224

TABLE 196            BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW   224

TABLE 197            UPEX-MED CO., LTD.: COMPANY OVERVIEW                 225

LIST OF FIGURES

FIGURE 1              ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION           24

FIGURE 2              RESEARCH DESIGN         28

FIGURE 3              PRIMARY SOURCES         30

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND

DEMAND-SIDE PARTICIPANTS  32

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION            33

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):

BY END USER, DESIGNATION, AND REGION        33

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         34

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION           35

FIGURE 9              SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL

DISSECTION MARKET (2024)       36

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)          37

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 38

FIGURE 12            TOP-DOWN APPROACH                38

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 40

FIGURE 14            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      43

FIGURE 15            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,

2025 VS. 2030 (USD MILLION)      44

FIGURE 16            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      44

FIGURE 17            GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET      45

FIGURE 18            INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH          46

FIGURE 19            GASTROSCOPES & COLONOSCOPES HELD LARGEST SHARE OF

ASIA PACIFIC MARKET IN 2024   47

FIGURE 20            MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD          48

FIGURE 21            ASIA PACIFIC TO BE LARGEST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET      48

FIGURE 22            DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE

DURING FORECAST PERIOD       49

FIGURE 23            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    50

FIGURE 24            GLOBAL CANCER INCIDENCE, 2022–2050                 51

FIGURE 25            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM ANALYSIS              62

FIGURE 26            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS           63

FIGURE 27            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:

PORTER’S FIVE FORCES ANALYSIS           64

FIGURE 28            AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD)             68

FIGURE 29            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: TOP PATENT OWNERS/APPLICANTS AND NUMBER OF PATENTS GRANTED,

JANUARY 2015–JUNE 2025              69

FIGURE 30            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:

STAKEHOLDERS IN SUPPLY CHAIN          73

FIGURE 31            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS           75

FIGURE 32            KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 75

FIGURE 33            IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024            77

FIGURE 34            EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS,

BY COUNTRY, 2020-2024                 79

FIGURE 35            KEY FEATURES OF GEN AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET      86

FIGURE 36            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION)            90

FIGURE 37            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE OF INVESTOR DEALS,

BY KEY PLAYER, 2019–2023 (USD MILLION)           90

FIGURE 38            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: NUMBER OF

INVESTOR DEALS, BY KEY PLAYER, 2019–2023      91

FIGURE 39            ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT            120

FIGURE 40            NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT            134

FIGURE 41            REVENUE ANALYSIS OF TOP PLAYERS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2020–2024 (USD MILLION) 169

FIGURE 42            MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024        170

FIGURE 43            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 173

FIGURE 44            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY FOOTPRINT             174

FIGURE 45            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024        179

FIGURE 46            EV/EBITDA OF KEY VENDORS   182

FIGURE 47            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                183

FIGURE 48            ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: BRAND/PRODUCT COMPARISON         183

FIGURE 49            OLYMPUS CORPORATION: COMPANY SNAPSHOT          188

FIGURE 50            MEDTRONIC: COMPANY SNAPSHOT      192

FIGURE 51            FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT   194

FIGURE 52            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT   198

FIGURE 53            SUMITOMO BAKELITE CO., LTD.: COMPANY SNAPSHOT          200

FIGURE 54            CREO MEDICAL GROUP PLC: COMPANY SNAPSHOT          202

FIGURE 55            HOYA CORPORATION: COMPANY SNAPSHOT                 205

FIGURE 56            CONMED CORPORATION: COMPANY SNAPSHOT          208

FIGURE 57            STERIS: COMPANY SNAPSHOT  210

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧